Refine by
Early Cancer Detection Suppliers & Manufacturers
33 companies found
based inSan Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables ...
based inCarlsbad, CALIFORNIA (USA)
We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools. Both the LumaGEM ® Molecular Breast Imaging (MBI) system and ...
The LumaGEM® Molecular Breast Imaging system’s patented mounting mechanism allows the use of light breast immobilization for greater patient comfort during breast cancer imaging exam. The LumaGEM MBI system for breast cancer imaging ...
based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
based inMiserey, FRANCE
Innovative Solutions for Cancer Diagnostics. OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most ...
based inAustin, TEXAS (USA)
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection of oral cancer. Our point–of–care solution is simple, accurate† and cost–effective–empowering clinicians to improve potential outcomes through ...
Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early ...
based inSeville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
based inJena, GERMANY
As a biotechnology company, we at oncgnostics GmbH have been working on the diagnosis of cancer on a molecular biological basis since 2012. Our cancer tests are used in early cancer detection and diagnosis.Our first product, GynTect®, was developed ...
based inHerndon, VIRGINIA (USA)
VIDAR Systems Corporation is a publicly held optical imaging technology manufacturing company, specializing in medical and non-destructive testing (NDT) imaging markets. VIDAR is owned by 3D Systems, a leading global provider of 3D content-to-print ...
CAD systems incorporate advanced pattern recognition and image analysis, requiring a film digitizer that meets the highest standards of image quality and reliability. These advanced systems enable radiologists to improve their ability to ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inSykesville, MARYLAND (USA)
OTraces, Inc. has built, and extensively filed patents protection on, an early tumor detection and cancer screening software technology. Technology uses well-known math- and physics-based A-I methods including those used in advanced satellite ...
based inSeoul, SOUTH KOREA
We make software that transforms medical data into deeper insight. Our AI technology takes medical intelligence to the next level: data-driven medicine. We aim to solve the most critical issues in cancer care today: reduce medical cost and prolong ...
Lunit INSIGHT CXR covers the vast majority of findings. Accurately detects 10 of the most common findings in a chest x-ray. Developed by using Lunit’s cutting-edge deep learning ...
based inAmsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inPhoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Smart, Accurate, & Dynamic. Our AI Learns about Your Cells Fast. In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are ...
based inCleveland, OHIO (USA)
Cleveland Diagnostics, Inc. is a commercial-stage diagnostics company developing highly efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. The Company’s Solvent Interaction Analysis ...
IsoPSA Proceed to biopsy only when needed. IsoPSA is now included in NCCN® Prostate Cancer Early Detection Guidelines. IsoPSA can help reduce unnecessary prostate biopsies by up to 55%. Up to ...
based inMenlo Park, CALIFORNIA (USA)
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power ...
GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Through what we believe to be one of the ...
based inGuangzhou, CHINA
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy ...